Trial Profile
A trial to staging early hepatocellular carcinoma with gadoxetic acid-enhanced magnetic resonance imaging and improvement in survival
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- 23 Dec 2015 New trial record